Skip to main content
. 2019 Dec 10;93(24):e2294–e2305. doi: 10.1212/WNL.0000000000008620

Table 2.

Overall summary of adverse events (AE) and serious AEs (SAEs) by treatment group: safety population

graphic file with name NEUROLOGY2018963033TT2.jpg